EFEarnings Feed

Filing detail

8-KTicker BBOTCIK 0001869105

BridgeBio Oncology Therapeutics, Inc. 8-K

Accession 0001193125-25-277601

Filed Nov 11, 7:00 PM ETAccepted Nov 12, 11:12 AM ETSize 211.4 KB
View on sec.gov ↗Open company profile

Filed (ET)

Nov 11, 7:00 PM ET

Accepted

Nov 12, 11:12 AM ET

File size

211.4 KB

SEC accession

0001193125-25-277601

Filing details

Company
BridgeBio Oncology Therapeutics, Inc.
CIK
0001869105
Incorporated
DE
Entity type
operating

Related parties

  • filerCIK 0001869105

Documents

Attached files
13 items